The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Toxicological Relevance of Pharmaceuticals in Drinking Water
Abstract
Interest in the public health significance of trace levels of pharmaceuticals in potable water is increasing, particularly with regard to the effects of long-term, low-dose exposures. To assess health risks and establish target concentrations for water treatment, human health risk-based screening levels for 15 pharmaceutically active ingredients and four metabolites were compared to concentrations detected at 19 drinking water treatment plants across the United States. Compounds were selected based on rate of use, likelihood of occurrence, and potential for toxicity. Screening levels were established based on animal toxicity data and adverse effects at therapeutic doses, focusing largely on reproductive and developmental toxicity and carcinogenicity. Calculated drinking water equivalent levels (DWELs) ranged from 0.49 microg/L (risperidone) to 20,000 microg/L (naproxen). None of the 10 detected compounds exceeded their DWEL. Ratios of DWELs to maximum detected concentrations ranged from 110 (phenytoin) to 6,000,000 (sulfamethoxazole). Based on this evaluation, adverse health effects from targeted pharmaceuticals occurring in U.S. drinking water are not expected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., & Buxton, H. T. (2002) · Environmental Science & Technology · doi:10.1021/es011055j · Cited by 7,953
Pharmaceuticals and personal care products in the environment: agents of subtle change?
Daughton, C. G., & Ternes, T. A. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s6907 · Cited by 4,705
Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water
Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D., & Snyder, S. A. (2009) · Environmental Science & Technology · doi:10.1021/es801845a · Cited by 1,681
Self-citationCasarett & Doull's Toxicology: The Basic Science of Poisons
Klaassen, C. D. (1998) · Cited by 1,179
Stackelberg, P. E., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Henderson, A. K., & Reissman, D. B. (2004) · Science of The Total Environment · doi:10.1016/j.scitotenv.2004.03.015 · Cited by 1,062
Ternes, T. A., Stüber, J., Herrmann, N., McDowell, D., Ried, A., Kampmann, M., & Teiser, B. (2003) · Water Research · doi:10.1016/s0043-1354(02)00570-5 · Cited by 995
Stackelberg, P. E., Gibs, J., Furlong, E. T., Meyer, M. T., Zaugg, S. D., & Lippincott, R. L. (2007) · Science of The Total Environment · doi:10.1016/j.scitotenv.2007.01.095 · Cited by 749
Glassmeyer, S. T., Furlong, E. T., Kolpin, D. W., Cahill, J. D., Zaugg, S. D., Werner, S. L., Meyer, M. T., & Kryak, D. D. (2005) · Environmental Science & Technology · doi:10.1021/es048120k · Cited by 708
Presence of therapeutic drugs in the environment
Zuccato, E., Calamari, D., Natangelo, M., & Fanelli, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02270-4 · Cited by 702
Loraine, G. A., & Pettigrove, M. E. (2006) · Environmental Science & Technology · doi:10.1021/es051380x · Cited by 648
Vieno, N. M., Tuhkanen, T., & Kronberg, L. (2005) · Environmental Science & Technology · doi:10.1021/es051124k · Cited by 540
Vanderford, B. J., Pearson, R. A., Rexing, D. J., & Snyder, S. A. (2003) · Analytical Chemistry · doi:10.1021/ac034210g · Cited by 461
Self-citationHuman pharmaceuticals in US surface waters: A human health risk assessment
Schwab, B. W., Hayes, E. P., Fiori, J. M., Mastrocco, F. J., Roden, N. M., Cragin, D., Meyerhoff, R. D., D’Aco, V. J., & Anderson, P. D. (2005) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2005.05.005 · Cited by 415
Toxicological relevance of emerging contaminants for drinking water quality
Schriks, M., Heringa, M. B., van der Kooi, M. M. E., de Voogt, P., & van Wezel, A. P. (2010) · Water Research · doi:10.1016/j.watres.2009.08.023 · Cited by 411
Indirect human exposure to pharmaceuticals via drinking water
Webb, S., Ternes, T., Gibert, M., & Olejniczak, K. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00071-7 · Cited by 372
Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment
Cunningham, V. L., Binks, S. P., & Olson, M. J. (2009) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2008.10.006 · Cited by 263
Antibiotic Resistance of Gram-Negative Bacteria in Rivers, United States
Ash, R. J., Mauck, B., & Morgan, M. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0807.010264 · Cited by 255
Pharmaceuticals in the Environment—A Human Risk?
Christensen, F. M. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1253 · Cited by 243
Barnes, K. K., Christenson, S. C., Kolpin, D. W., Focazio, M. J., Furlong, E. T., Zaugg, S. D., Meyer, M. T., & Barber, L. B. (2004) · Groundwater Monitoring & Remediation · doi:10.1111/j.1745-6592.2004.tb00720.x · Cited by 201
Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process
Thomas, P. M., & Foster, G. D. (2005) · Environmental Toxicology and Chemistry · doi:10.1897/04-144r.1 · Cited by 195
Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes
Lei, H., & Wert, E. C. (2007) · Cited by 171
Durán-Alvarez, J. C., Becerril-Bravo, E., Castro, V. S., Jiménez, B., & Gibson, R. (2009) · Talanta · doi:10.1016/j.talanta.2009.01.035 · Cited by 168
Gross, B., Montgomery-Brown, J., Naumann, A., & Reinhard, M. (2004) · Environmental Toxicology and Chemistry · doi:10.1897/03-606 · Cited by 166
Huschek, G., Hansen, P., Maurer, H. H., Krengel, D., & Kayser, A. (2004) · Environmental Toxicology · doi:10.1002/tox.20015 · Cited by 149
A Human Health Risk Assessment of Pharmaceuticals in the Aquatic Environment
Schulman, L., Sargent, E. V., Naumann, B. D., Faria, E. C., Dolan, D. G., & Wargo, J. P. (2002) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/20028091057141 · Cited by 145
Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment
Tabacova, S. A., Little, R., Tsong, Y., Vega, A., & Kimmel, C. A. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.796 · Cited by 124
Pharmaceutical Contaminants in Potable Water: Potential Concerns for Pregnant Women and Children
Collier, A. C. (2007) · EcoHealth · doi:10.1007/s10393-007-0105-5 · Cited by 110
Kumar, A., & Xagoraraki, I. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.02.002 · Cited by 99
Carcinogen Bioassay and Mutagenicity Studies With the Hypolipidemic Agent Gemfibrozil 2
Fitzgerald, J. E., Sanyer, J. L., Schardein, J. L., et al. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/67.5.1105 · Cited by 77
Kellogg, C. K., Primus, R. J., & Bitran, D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23019-1 · Cited by 68
Pharmaceuticals and Personal Care Products in the Waters of Lake Mead, Nevada
Snyder, S. A., Kelly, K. L., Grange, A. H., Sovocool, G. W., Snyder, E. M., & Giesy, J. P. (2001) · ACS symposium series · doi:10.1021/bk-2001-0791.ch007 · Cited by 58
Self-citationHuman health risk assessments for three neuropharmaceutical compounds in surface waters
Bercu, J. P., Parke, N. J., Fiori, J. M., et al. (2008) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2008.01.014 · Cited by 55
Lee, K. E., Barber, L. B., Furlong, E. T., Cahill, J. D., Kolpin, D. W., Meyer, M. T., & Zaugg, S. D. (2004) · Scientific investigations report · doi:10.3133/sir20045138 · Cited by 52
Formation of meprobamate from carisoprodol is catalysed byCYP2C19
Dal??n, P., Alván, G., Wakelkamp, M., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199610000-00002 · Cited by 45
Developmental, Neuro and Immunotoxic Effects of Perinatal Diazepam Treatment in Rats
da Silva, F. R. D. F. R., & Palermo‐Neto, J. (1999) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979909052761 · Cited by 29
Boyd, R. A., & Furlong, E. T. (2002) · Antarctica A Keystone in a Changing World · doi:10.3133/ofr02385 · Cited by 20
Drug resistance in Detroit River gram-negative bacilli.
Campeau, R. C., Gulli, L. F., & Graves, J. F. (1996) · PubMed · Cited by 10
Cited by
Pal, A., He, Y., Jekel, M., Reinhard, M., & Gin, K. Y.-H. (2014) · Environment International · doi:10.1016/j.envint.2014.05.025 · Cited by 492
Tijani, J. O., Fatoba, O. O., Babajide, O. O., & Petrik, L. F. (2016) · Environmental Chemistry Letters · doi:10.1007/s10311-015-0537-z · Cited by 473
Padhye, L. P., Yao, H., Kung'u, F. T., & Huang, C.-H. (2014) · Water Research · doi:10.1016/j.watres.2013.10.070 · Cited by 437
Klosterhaus, S. L., Grace, R., Hamilton, M. C., & Yee, D. (2013) · Environment International · doi:10.1016/j.envint.2013.01.009 · Cited by 368
Schaider, L. A., Rudel, R. A., Ackerman, J. M., Dunagan, S. C., & Brody, J. G. (2014) · Science of The Total Environment · doi:10.1016/j.scitotenv.2013.08.067 · Cited by 304
Metadata
- Authors
- Bruce, G. M., Pleus, R. C., & Snyder, S. A.
- Venue
- Environmental Science & Technology
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-06-24
- Volume
- 44
- Issue
- 14
- Pages
- 5619-5626
- ISSN
- 0013-936X (ISSN-L)
- 1520-5851
- OpenAlex
- W2071382991
- Cited by
- 253
- References
- 38
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.